Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
Dermatologists reported low satisfaction with traditional AA therapies used in patients with extensive SHL, with some patients discontinuing treatment because of worsening disease. This suggests more effective treatments are needed for patients with severe AA.
Authors
- Samantha K. Kurosky (ORCID: https://orcid.org/0000-0003-2392-8111)
- Sergio Vañó‐Galván (ORCID: https://orcid.org/0000-0003-2773-7494)
- James Piercy (ORCID: https://orcid.org/0000-0001-7015-1021)
- Simran Marwaha (ORCID: https://orcid.org/0000-0003-0380-0372)
- Peter Anderson (ORCID: https://orcid.org/0000-0002-2171-8228)
- Ernest H. Law (ORCID: https://orcid.org/0000-0002-6111-8008)
- Gregor Schaefer
- Kent A. Hanson (ORCID: https://orcid.org/0000-0002-7201-3324)
- Jenny Austin (ORCID: https://orcid.org/0000-0003-4297-6290)
Institutions
- Pfizer (United States) (US)
- Universidad de Alcalá (ES)
- University of Illinois Chicago (US)
- Adelphi Group (United Kingdom) (GB)
- Pfizer (Germany) (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1007/s13555-024-01280-3
- Citations
- 2
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Pfizer